Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review

Ronald Melnick, George Lucier, Mary Wolfe, Roxanne Hall, George Stancel, Gail Prins, Michael Gallo, Kenneth Reuhl, Shuk Mei Ho, Terry Brown, John Moore, Julian Leakey, Joseph Haseman, Michael Kohn

Research output: Contribution to journalArticle

Abstract

At the request of the U.S. Environmental Protection Agency (U.S. EPA), the National Toxicology Program organized an independent and open peer review to evaluate the scientific evidence on low-dose effects and nonmonotonic dose-response relationships for endocrine-disrupting chemicals in mammalian species. For this peer review, "low-dose effects" referred to biologic changes that occur in the range of human exposures or at doses lower than those typically used in the standard testing paradigm of the U.S. EPA for evaluating reproductive and developmental toxicity. The demonstration that an effect is adverse was not required because in many cases the long-term health consequences of altered endocrine function during development have not been fully characterized. A unique aspect of this peer review was the willing submission of individual animal data by principal investigators of primary research groups active in this field and the independent statistical reanalyses of selected parameters prior to the peer review meeting by a subpanel of statisticians. The expert peer-review panel (the panel) also considered mechanistic data that might influence the plausibility of low-dose effects and identified study design issues or other biologic factors that might account for differences in reported outcomes among studies. The panel found that low-dose effects, as defined for this review, have been demonstrated in laboratory animals exposed to certain endocrine-active agents. In some cases where low-dose effects have been reported, the findings have not been replicated. The shape of the dose-response curves for reported effects varied with the end point and dosing regimen and were low-dose linear, threshold-appearing, or nonmonotonic. The findings of the panel indicate that the current testing paradigm used for assessments of reproductive and developmental toxicity should be revisited to see whether changes are needed regarding dose selection, animal-model selection, age when animals are evaluated, and the end points being measured following exposure to endocrine-active agents.

Original languageEnglish (US)
Pages (from-to)427-431
Number of pages5
JournalEnvironmental Health Perspectives
Volume110
Issue number4
StatePublished - 2002

Fingerprint

Endocrine Disruptors
Peer Review
endocrine disruptor
toxicology
Toxicology
Animals
United States Environmental Protection Agency
Environmental Protection Agency
Toxicity
animal
Laboratory Animals
Biological Factors
Testing
Animal Models
toxicity
Research Personnel
Outcome Assessment (Health Care)
programme
dose
Demonstrations

Keywords

  • Androgen
  • Antiandrogen
  • Bisphenol A
  • Developmental toxicity
  • Endocrine disruptors
  • Estrogen
  • In utero exposure
  • Low-dose effects
  • Multigeneration study
  • Neonatal exposure
  • Reproductive toxicity

ASJC Scopus subject areas

  • Environmental Science(all)
  • Environmental Chemistry
  • Public Health, Environmental and Occupational Health

Cite this

Melnick, R., Lucier, G., Wolfe, M., Hall, R., Stancel, G., Prins, G., ... Kohn, M. (2002). Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review. Environmental Health Perspectives, 110(4), 427-431.

Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review. / Melnick, Ronald; Lucier, George; Wolfe, Mary; Hall, Roxanne; Stancel, George; Prins, Gail; Gallo, Michael; Reuhl, Kenneth; Ho, Shuk Mei; Brown, Terry; Moore, John; Leakey, Julian; Haseman, Joseph; Kohn, Michael.

In: Environmental Health Perspectives, Vol. 110, No. 4, 2002, p. 427-431.

Research output: Contribution to journalArticle

Melnick, R, Lucier, G, Wolfe, M, Hall, R, Stancel, G, Prins, G, Gallo, M, Reuhl, K, Ho, SM, Brown, T, Moore, J, Leakey, J, Haseman, J & Kohn, M 2002, 'Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review', Environmental Health Perspectives, vol. 110, no. 4, pp. 427-431.
Melnick, Ronald ; Lucier, George ; Wolfe, Mary ; Hall, Roxanne ; Stancel, George ; Prins, Gail ; Gallo, Michael ; Reuhl, Kenneth ; Ho, Shuk Mei ; Brown, Terry ; Moore, John ; Leakey, Julian ; Haseman, Joseph ; Kohn, Michael. / Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review. In: Environmental Health Perspectives. 2002 ; Vol. 110, No. 4. pp. 427-431.
@article{f28ad4f1f69f41ef8ad49fa78cae1664,
title = "Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review",
abstract = "At the request of the U.S. Environmental Protection Agency (U.S. EPA), the National Toxicology Program organized an independent and open peer review to evaluate the scientific evidence on low-dose effects and nonmonotonic dose-response relationships for endocrine-disrupting chemicals in mammalian species. For this peer review, {"}low-dose effects{"} referred to biologic changes that occur in the range of human exposures or at doses lower than those typically used in the standard testing paradigm of the U.S. EPA for evaluating reproductive and developmental toxicity. The demonstration that an effect is adverse was not required because in many cases the long-term health consequences of altered endocrine function during development have not been fully characterized. A unique aspect of this peer review was the willing submission of individual animal data by principal investigators of primary research groups active in this field and the independent statistical reanalyses of selected parameters prior to the peer review meeting by a subpanel of statisticians. The expert peer-review panel (the panel) also considered mechanistic data that might influence the plausibility of low-dose effects and identified study design issues or other biologic factors that might account for differences in reported outcomes among studies. The panel found that low-dose effects, as defined for this review, have been demonstrated in laboratory animals exposed to certain endocrine-active agents. In some cases where low-dose effects have been reported, the findings have not been replicated. The shape of the dose-response curves for reported effects varied with the end point and dosing regimen and were low-dose linear, threshold-appearing, or nonmonotonic. The findings of the panel indicate that the current testing paradigm used for assessments of reproductive and developmental toxicity should be revisited to see whether changes are needed regarding dose selection, animal-model selection, age when animals are evaluated, and the end points being measured following exposure to endocrine-active agents.",
keywords = "Androgen, Antiandrogen, Bisphenol A, Developmental toxicity, Endocrine disruptors, Estrogen, In utero exposure, Low-dose effects, Multigeneration study, Neonatal exposure, Reproductive toxicity",
author = "Ronald Melnick and George Lucier and Mary Wolfe and Roxanne Hall and George Stancel and Gail Prins and Michael Gallo and Kenneth Reuhl and Ho, {Shuk Mei} and Terry Brown and John Moore and Julian Leakey and Joseph Haseman and Michael Kohn",
year = "2002",
language = "English (US)",
volume = "110",
pages = "427--431",
journal = "Environmental Health Perspectives",
issn = "0091-6765",
publisher = "Public Health Services, US Dept of Health and Human Services",
number = "4",

}

TY - JOUR

T1 - Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review

AU - Melnick, Ronald

AU - Lucier, George

AU - Wolfe, Mary

AU - Hall, Roxanne

AU - Stancel, George

AU - Prins, Gail

AU - Gallo, Michael

AU - Reuhl, Kenneth

AU - Ho, Shuk Mei

AU - Brown, Terry

AU - Moore, John

AU - Leakey, Julian

AU - Haseman, Joseph

AU - Kohn, Michael

PY - 2002

Y1 - 2002

N2 - At the request of the U.S. Environmental Protection Agency (U.S. EPA), the National Toxicology Program organized an independent and open peer review to evaluate the scientific evidence on low-dose effects and nonmonotonic dose-response relationships for endocrine-disrupting chemicals in mammalian species. For this peer review, "low-dose effects" referred to biologic changes that occur in the range of human exposures or at doses lower than those typically used in the standard testing paradigm of the U.S. EPA for evaluating reproductive and developmental toxicity. The demonstration that an effect is adverse was not required because in many cases the long-term health consequences of altered endocrine function during development have not been fully characterized. A unique aspect of this peer review was the willing submission of individual animal data by principal investigators of primary research groups active in this field and the independent statistical reanalyses of selected parameters prior to the peer review meeting by a subpanel of statisticians. The expert peer-review panel (the panel) also considered mechanistic data that might influence the plausibility of low-dose effects and identified study design issues or other biologic factors that might account for differences in reported outcomes among studies. The panel found that low-dose effects, as defined for this review, have been demonstrated in laboratory animals exposed to certain endocrine-active agents. In some cases where low-dose effects have been reported, the findings have not been replicated. The shape of the dose-response curves for reported effects varied with the end point and dosing regimen and were low-dose linear, threshold-appearing, or nonmonotonic. The findings of the panel indicate that the current testing paradigm used for assessments of reproductive and developmental toxicity should be revisited to see whether changes are needed regarding dose selection, animal-model selection, age when animals are evaluated, and the end points being measured following exposure to endocrine-active agents.

AB - At the request of the U.S. Environmental Protection Agency (U.S. EPA), the National Toxicology Program organized an independent and open peer review to evaluate the scientific evidence on low-dose effects and nonmonotonic dose-response relationships for endocrine-disrupting chemicals in mammalian species. For this peer review, "low-dose effects" referred to biologic changes that occur in the range of human exposures or at doses lower than those typically used in the standard testing paradigm of the U.S. EPA for evaluating reproductive and developmental toxicity. The demonstration that an effect is adverse was not required because in many cases the long-term health consequences of altered endocrine function during development have not been fully characterized. A unique aspect of this peer review was the willing submission of individual animal data by principal investigators of primary research groups active in this field and the independent statistical reanalyses of selected parameters prior to the peer review meeting by a subpanel of statisticians. The expert peer-review panel (the panel) also considered mechanistic data that might influence the plausibility of low-dose effects and identified study design issues or other biologic factors that might account for differences in reported outcomes among studies. The panel found that low-dose effects, as defined for this review, have been demonstrated in laboratory animals exposed to certain endocrine-active agents. In some cases where low-dose effects have been reported, the findings have not been replicated. The shape of the dose-response curves for reported effects varied with the end point and dosing regimen and were low-dose linear, threshold-appearing, or nonmonotonic. The findings of the panel indicate that the current testing paradigm used for assessments of reproductive and developmental toxicity should be revisited to see whether changes are needed regarding dose selection, animal-model selection, age when animals are evaluated, and the end points being measured following exposure to endocrine-active agents.

KW - Androgen

KW - Antiandrogen

KW - Bisphenol A

KW - Developmental toxicity

KW - Endocrine disruptors

KW - Estrogen

KW - In utero exposure

KW - Low-dose effects

KW - Multigeneration study

KW - Neonatal exposure

KW - Reproductive toxicity

UR - http://www.scopus.com/inward/record.url?scp=0036228631&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036228631&partnerID=8YFLogxK

M3 - Article

C2 - 11940462

AN - SCOPUS:0036228631

VL - 110

SP - 427

EP - 431

JO - Environmental Health Perspectives

JF - Environmental Health Perspectives

SN - 0091-6765

IS - 4

ER -